Draig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Developing transformative, best-in-class neuropsychiatric therapies
Develops next-generation therapies for migraine prevention
Pitching Canaan Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room